Solventum (SOLV)

• Market cap: $12.6B
• 1 day: -1.99%
• 5 days: -2.30%
• 1 month: -1.35%
• 3 months: 4.87%
• 6 months: 22.39%
• Year to date: 10.75%
• 1 year: -8.73%
• 5 years: -8.73%
• 10 years: -8.73%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.

Employees: 22,000

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

44% more call options, than puts

Call options by funds: $42.1M | Put options by funds: $29.1M

2.58% more ownership

Funds ownership: 60.86% [Q3] → 63.44% (+2.58%) [Q4]

9% more first-time investments, than exits

New positions opened: 114 | Existing positions closed: 105

2% more capital invested

Capital invested by funds: $7.35B [Q3] → $7.51B (+$156M) [Q4]

4% less funds holding

Funds holding: 920 [Q3] → 884 (-36) [Q4]

18% less funds holding in top 10

Funds holding in top 10: 11 [Q3] → 9 (-2) [Q4]

51% less repeat investments, than reductions

Existing positions increased: 190 | Existing positions reduced: 387

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $70 4% downside
• Avg. target: $70 4% downside
• High target: $70 4% downside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

Mizuho Steven Valiquette 40% 1-year accuracy 2 / 5 met price target

4% downside $70

Neutral Initiated

4 Dec 2024